MULTIGEN
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79404951
- Registration number
- 8182066
- Mark type
- Stylized text
- Filed
- 09 Jul 2024
- Published for opposition
- 03 Feb 2026
- Registered
- 24 Mar 2026
- Attorney of record
- Jessica S. Sachs
Goods and services
- Class 001 — Chemicals: Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); chemical substances for use in the production of drugs; biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs); none of the foregoing for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies
- Class 005 — Pharmaceuticals: chemical and biochemical substances for pharmaceutical or veterinary use screened by means of stabilized proteins, namely, small molecules and antibodies for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; veterinary products, namely, antigens and reagents for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; none of the foregoing for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies
- Class 035 — Advertising and business services: Collating of data in computer databases; computerized file management; data processing; automated processing of medical and pharmaceutical data; compilation of statistical data relating to medical research and development; computer database management; none of the foregoing services for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies
- Class 042 — Scientific and technological services: Medical and pharmacological research services; pharmaceutical drug development services; laboratory research services relating to pharmaceuticals; research and development of vaccines and medicines; scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); design of computer databases; updating of database software; data warehousing; provision of information and data relating to medical research and development; rendering of computer graphics featuring digital image correction for research and development; computer graphic design services featuring data and image processing services for making three dimensional models; non-medical graphic design featuring digital imaging services; optical imaging for use in research and development of medicines; imaging via computers for use in research and development of medicines; graphic design services for generating and processing data and images for making three dimensional models for use in research and development of medicines; none of the foregoing services for vitamin supplements, for vitamin supplements or generic pharmaceuticals dispensed by prescription, or for vitamin supplements or generic pharmaceuticals distributed to pharmacies or wholesale distributors selling to pharmacies
Owner
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 29 Jan 2026 — NOTIFICATION PROCESSED BY IB
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jan 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 13 Jan 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 06 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Dec 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 27 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 27 Oct 2025 — FINAL REFUSAL E-MAILED
- 27 Oct 2025 — FINAL REFUSAL WRITTEN